Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
CorMedix
CorMedix
(CRMD)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Defencath
Heparin
,
Taurolidine
2023-11-15
2024-2042
Myocardial infarction
,
Pulmonary embolism
,
Postoperative complications
,
Thromboembolism
,
Cerebral infarction
,
Coronary thrombosis
,
Unstable angina
,
Thrombophlebitis
,
Migraine disorders
,
Pain
,
Ventricular tachycardia
,
Orthostatic hypotension
,
Cardiac arrhythmias
,
Cluster headache
,
Postpartum hemorrhage
,
Xerostomia
,
Burns
,
Esophageal diseases
,
Ventricular fibrillation
,
Ventricular premature complexes
,
Mouth diseases
,
Paroxysmal tachycardia
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Heparin
injection site reaction
Taurolidine
sepsis
,
infections
,
communicable diseases
,
chronic kidney failure
,
renal insufficiency
,
catheter-related infections
Heparin sodium
injection site reaction
Corticorelin
chronic kidney failure
,
renal insufficiency
,
sepsis
,
infections
,
communicable diseases
,
catheter-related infections
Nepidermin
glioblastoma
,
glioma
,
hypertension
,
pulmonary hypertension
,
pulmonary arterial hypertension
,
heart failure
,
pulmonary edema
,
lymphoma
,
squamous cell carcinoma
,
squamous cell neoplasms
,
prostatic neoplasms
,
peritoneal neoplasms
,
breast neoplasms
,
hiv infections
,
infections
,
ovarian neoplasms
,
acquired immunodeficiency syndrome
,
neoplasms
,
communicable diseases
,
neoplasm metastasis
,
melanoma
,
anemia
,
premature obstetric labor
,
nasal polyps
,
ovarian epithelial carcinoma
,
overactive urinary bladder
,
non-small-cell lung carcinoma
,
chronic renal insufficiency
,
kidney diseases
,
thrombocytopenic purpura idiopathic
,
thrombocytopenic purpura
,
purpura
,
vomiting
,
nausea
,
head and neck neoplasms
,
renal cell carcinoma
,
lung neoplasms
,
urinary tract infections
,
recurrence
,
non-hodgkin lymphoma
,
fallopian tube neoplasms
,
endometrial neoplasms
,
erectile dysfunction
,
gonorrhea
,
muscle spasticity
,
urinary incontinence
,
enuresis
,
postmenopausal osteoporosis
,
stomach neoplasms
,
gastrointestinal neoplasms
,
acute coronary syndrome
,
syndrome
,
parkinson disease
,
respiratory tract diseases
,
orthomyxoviridae infections
,
human influenza
,
sarcoma
,
carcinoma
,
brain neoplasms
,
small cell lung carcinoma
,
thrombosis
,
venous thrombosis
,
thrombophlebitis
,
polyps
,
rhinosinusitis
,
herpes simplex
,
postoperative nausea and vomiting
,
post-traumatic stress disorders
,
traumatic stress disorders
,
whooping cough
,
tetanus
,
diphtheria
,
triple negative breast neoplasms
,
mucinous adenocarcinoma
,
ductal carcinoma breast
,
inflammatory breast neoplasms
,
immunologic deficiency syndromes
,
atherosclerosis
,
onychomycosis
,
covid-19
,
systemic lupus erythematosus
,
coronary disease
,
coronary artery disease
,
myocardial ischemia
,
heart diseases
,
exanthema
Neutrolin
chronic kidney failure
,
renal insufficiency
,
sepsis
,
infections
,
communicable diseases
,
catheter-related infections
,
thrombosis
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use